What is believed to be the world's largest seizure of counterfeit weight loss jabs has taken place in the UK.

Cipla collaboration brings a second brand of tirzepatide, Yurpeak, to India, aiming to widen patient access for diabetes and ...

The first illicit production facility for weight loss medicine found in the UK has been dismantled. The discovery, in ...

Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...

Eli Lilly ( NYSE: LLY) has partnered with India's Cipla to market its weight-loss medication Tirzepatide under a new brand in ...

Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in obesity-related heart failure with preserved ejection fraction.

New guidance from the European Association for the Study of Obesity says that semaglutide or tirzepatide should be first-line ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

A haul of fake weight-loss jabs worth more than £250,000 has been seized from a warehouse in Northampton in a ...

A recent Northwestern Medicine study has identified novel neural circuits modulated by the diabetes and obesity-management ...

Cipla and Eli Lilly India have announced an agreement to distribute a type 2 diabetes drug, tirzepatide, under the new brand ...

Around £250,000 worth of fake weight-loss jabs have been seized in what is thought to be the biggest crackdown on the illicit ...